Literature DB >> 2673839

Presence of a basic amino acid residue at either position 66 or 122 is a condition for enzymic activity in the ribonuclease superfamily.

J J Beintema1.   

Abstract

Some members of the ribonuclease superfamily differ at more than 50% of the amino acid positions. Although the three-dimensional structures probably are very similar and the active-site residues have been conserved, other substrate-binding regions have changed considerably. Several proteins in the superfamily are active ribonucleases while other exhibit practically no enzymic activity. The presence of a basic residue at either position 66 or 122 appears to be a condition for ribonuclease activity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2673839     DOI: 10.1016/0014-5793(89)80996-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  5 in total

1.  Complementary advantageous substitutions in the evolution of an antiviral RNase of higher primates.

Authors:  Jianzhi Zhang; Helene F Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-26       Impact factor: 11.205

2.  Diversity among the primate eosinophil-derived neurotoxin genes: a specific C-terminal sequence is necessary for enhanced ribonuclease activity.

Authors:  H F Rosenberg; K D Dyer
Journal:  Nucleic Acids Res       Date:  1997-09-01       Impact factor: 16.971

3.  Enzymatic properties of newly found green turtle egg white ribonuclease.

Authors:  Somporn Katekaew; Takao Torikata; Hideki Hirakawa; Satoru Kuhara; Tomohiro Araki
Journal:  Protein J       Date:  2007-02       Impact factor: 2.371

4.  Role of aspartic acid 121 in human pancreatic ribonuclease catalysis.

Authors:  Deepak Gaur; Janendra K Batra
Journal:  Mol Cell Biochem       Date:  2005-07       Impact factor: 3.396

5.  Structural investigation of catalytically modified F120L and F120Y semisynthetic ribonucleases.

Authors:  V S deMel; M S Doscher; M A Glinn; P D Martin; M L Ram; B F Edwards
Journal:  Protein Sci       Date:  1994-01       Impact factor: 6.725

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.